BioConnect Ireland 'Biomarkers – Sensing the Future Challenges in the Road from the Bench to the Clinic'
Biomarkers are indicators of disease or health status and are a major area of healthcare investigation. They can provide vital information in disease prognosis, in prediction of patient responses to therapies and drug interactions, and they are also playing an increasingly important role in the discovery and development of new drugs. Discovery and validation of biomarkers is a major focus of current R&D investment. A recent US review showed that NIH funded almost 29,000 grants related to biomarkers over a recent 25 year period, at a total cost of $2.5billion. Funding within the EU is likely to have been similar. While this investment has resulted in the identification of many potential biomarkers, there has not been a parallel uptake of these new biomarkers for patient care.
FREE to attend. Registration by 27th October is required.
Tea/Coffee and Networking
3.00 Chair: Welcome and introduction
Dr. Cormac Kilty Biotech entrepreneur and investor
Commercialisation of Biomarkers: what works?
Prof. John Crown Consultant Medical Oncologist, St. Vincent’s University Hospital
Biomarker application: The clinical challenge
Fergus Fleming Senior Project Manager, EKF Diagnostics, Dublin
Predicting diabetic nephropathy: a case study in biomarker commercialisation
4.30 Open Mike
A series of short presentations from BioConnect Ireland members.
At BioConnect Ireland events, up to five individuals can get 3 minutes each to introduce themselves or their organisation to their BioConnect Ireland colleagues.
If you are interested in availing of an Open Mike slot, please email email@example.com
5.00 Network Reception
6.00 Event concludes